Why is Par Drugs & Che. falling/rising?

As of 12-Sep, Par Drugs & Chemicals Ltd is experiencing a decline in its stock price, currently at 108.64, reflecting a decrease of 4.93 points or 4.34%. Today's performance indicates that the stock has underperformed its sector by 5.22%. Over the past week, the stock has shown a return of +10.79%, which is significantly higher than the Sensex's +1.51%. However, the stock's year-to-date performance is concerning, with a decline of -45.38%, contrasting sharply with the Sensex's increase of +6.21%. The company has a low debt-to-equity ratio and a favorable return on equity of 14.6, suggesting attractive valuation metrics, yet it has faced negative results for the last three consecutive quarters, contributing to its recent price movement. Broader market context reveals that while the stock has performed well in the short term, it has significantly underperformed over the past year, with a staggering decline of -58.19% compared to the BSE500's -3.45%. This poor long-term growth is reflected in the company's net sales growth of only 12.10% annually over the last five years and a concerning operating profit growth of just 1.10%. The stock's recent decline can be attributed to these negative financial results, including a -20.32% drop in profit after tax over the latest six months, alongside a high proportion of non-operating income affecting profitability.